Cite
HARVARD Citation
Macaluso, F. et al. (n.d.). P436 SPOSAB ABP 501 - A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501. Journal of Crohn's and colitis. pp. S437-S438. [Online].